Back
AtriCure, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Sell
34
ATRC
AtriCure, Inc.
Last Price:
$39.51
Seasonality Move:
-5.18%
Sell
38
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
34
AtriCure, Inc. (ATRC)
is a Sell
Is AtriCure, Inc. a Buy, Sell or Hold?
-
The current AtriCure, Inc. [ATRC] share price is $40.18. The Score for ATRC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
ATRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATRC Stock Price Chart
What is AtriCure, Inc.'s stock price today?
-
The AtriCure, Inc. share price today is $40.18The current trend is moderately bearish and ATRC is experiencing slight selling pressure.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.
ATRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 56.02 | Buy |
| Chaikin Money Flow: | -27837 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.1 - 41.42) | Buy |
| Bollinger Bands (100): | (33.94 - 38.78) | Buy |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.71 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -220916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.11 - 35.93) | Sell |
| Bollinger Bands (100): | (16.49 - 33.77) | Buy |
ATRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.66 | Sell |
| 20-day SMA: | 39.84 | Buy |
| 50-day SMA: | 36.82 | Buy |
| 200-day SMA: | 34.46 | Buy |
| 8-day EMA: | 40.52 | Sell |
| 20-day EMA: | 39.64 | Buy |
| 50-day EMA: | 37.77 | Buy |
| 200-day EMA: | 35.21 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.03 | Sell |
| 20-day SMA: | 34.65 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 31.26 | Buy |
| 20-day EMA: | 20.72 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 3 | Buy |
AtriCure, Inc. Earnings Growth & ATRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.31 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
AtriCure, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||